Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesGastroenterologyAetna Double-Balloon Enteroscopy Coverage Update |…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentAetnaPolicy 0737

    Double Balloon Enteroscopy

    Customize your policy alerts

    Sign up for Aetna Policy 0737 alerts

    Get alerted when Policy 0737 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Clinical policy governing when double balloon enteroscopy is considered medically necessary or investigational for Aetna members; applies to evaluation and treatment of small bowel conditions and certain related indications.

    Policy Summary
    PayerAetna
    PolicyDouble Balloon Enteroscopy
    Policy CodePolicy 0737
    Change TypeNo material change
    Effective DateOct 5, 2007
    Last ReviewFeb 20, 2024
    Next Review DateAug 8, 2024
    Key ActionObtain prior authorization documenting that DBE is being performed for a listed medically necessary indication and include prior diagnostic work-up such as capsule endoscopy or imaging when applicable.
    SourceLink
    ≈75%diagnostic yield
    67%therapeutic yield
    90%enteroscopic success (DBE-ERCP)
    6.27%DBE-ERCP complications
    80%surgery avoided after dilation
    90 minsprocedure time

    Coverage criteria for double-balloon enteroscopy (DBE)

    inv-01: Medically necessary indications

    Covered when ANY of the following indications are met:

    Medically necessary indications for DBE: 1) Dilation of small bowel strictures in Crohn's disease; 2) Evaluation of suspected small-bowel malignancies (e.g., adenocarcinoma, lymphoma, GIST, metastatic tumors); 3) Evaluation of the colon after incomplete colonoscopy; 4) Suspected Meckel's diverticulum with indefinite diagnostic imaging work-up (e.g., CT, Meckel's scan); 5) Investigation of suspected small intestinal bleeding in individuals with objective evidence of recurrent obscure GI bleeding after negative EGD and colonoscopy; 6) Initial diagnosis in suspected Crohn's disease when conventional diagnostic tests (small-bowel follow-through, EGD, colonoscopy) are negative; 7) Removal of entrapped foreign bodies in the small bowel (e.g., retained video capsule); 8) Removal of large polyps (>10 mm) of the small bowel in Peutz-Jeghers syndrome; 9) Treatment of GI bleeding when the small intestine has been identified as the source of bleeding; 10) Use with ERCP in individuals with surgically altered upper GI anatomy.

    inv-02: Experimental/Investigational

    Considered experimental/investigational (Not covered) when used for:

    Experimental or investigational indications:
    Policy Summary
    PayerAetna
    PolicyDouble Balloon Enteroscopy
    Policy CodePolicy 0737
    Change TypeNo material change
    Effective DateOct 5, 2007
    Last ReviewFeb 20, 2024
    Next Review DateAug 8, 2024
    Key ActionObtain prior authorization documenting that DBE is being performed for a listed medically necessary indication and include prior diagnostic work-up such as capsule endoscopy or imaging when applicable.
    SourceLink
    On This Page
    Coverage criteria for double-balloon enteroscopy (DBE)Coding and billing referencesProvider actions, prior authorization, and documentationBackground and contextDefinitions and key terms
    Detection of neuroendocrine tumors of the small bowel; diagnosis of pelvic mass penetrating intestine, including gossypiboma; diagnosis of pyogenic granuloma; treatment of intussusception; treatment of post-operative bile leakage after hepatico-jejunostomy; and other indications not listed as medically necessary.

    inv-03: Covered clinical indications

    Clinical scenarios in which DBE is indicated based on cited evidence

    Indications: DBE may be indicated when ANY of the following are present: (1) Positive capsule endoscopy finding requiring biopsy or therapeutic intervention; (2) High clinical suspicion for small-bowel lesion despite negative capsule endoscopy; (3) Active small-bowel bleeding (obscure GI bleeding, OGIB); (4) Failed or incomplete conventional colonoscopy where DBE can achieve cecal intubation and allow interventions; (5) Management of sizable small-bowel polyps (e.g., Peutz-Jeghers syndrome) amenable to endoscopic resection; (6) Diagnosis of suspected Meckel's diverticulum when other modalities are inconclusive; (7) Facilitation of ERCP in patients with surgically altered GI anatomy where conventional endoscope cannot reach the papilla or biliary anastomosis.

    Derived from comparative studies, meta-analyses, and series showing higher diagnostic yield for DBE after positive CE and its therapeutic role.

    inv-04: General medical necessity criteria for DBE

    Covered when ALL of the following are met

    DBE indication: Patient has a clinical indication amenable to DBE (examples: suspected small-bowel bleeding/OGIB, retained video capsule, suspected small-bowel malignancy, Peutz-Jeghers polyps ≥10 mm, foreign body retrieval, or need for ERCP in surgically altered anatomy)

    Supported by policy-listed indications and evidence.

    Prior work-up: Appropriate prior noninvasive or less invasive evaluation has been performed and is documented as indicated (e.g., EGD and colonoscopy; capsule endoscopy when appropriate; CT/MR enterography; Meckel's scan when relevant)

    Evidence and guidelines recommend CE as initial test for OGIB and DBE commonly performed after positive CE or when CE is contraindicated or nondiagnostic.

    Technical plan and expertise: Procedure will be performed by an experienced endoscopist capable of the planned diagnostic or therapeutic interventions, or at a high-volume/referral center when complex surgically altered anatomy or advanced therapy is required

    Referral to high-volume centers suggested for altered anatomy ERCP and complex interventions.

    inv-05: Diagnosis of suspected Meckel's diverticulum

    Covered when supported by appropriate clinical indication and prior evaluation:

    DBE for suspected bleeding Meckel's diverticulum in adults: BAE/DBE is indicated for pre-operative diagnosis of bleeding Meckel's diverticulum in adults when noninvasive imaging (e.g., Meckel's scan, CT, MRI enterography) is negative or nondiagnostic and clinical suspicion persistsdiagnostic necessity after prior non-diagnostic imaging

    Multi-center study showed higher diagnostic accuracy for BAE/DBE (85.0%) versus Meckel's scan (21.4%) in adults.

    inv-06: DBE-ERCP in altered GI anatomy

    Covered when ALL of the following are met:

    DBE-ERCP for pancreatico-biliary disease in altered GI anatomy: DBE-ERCP is considered when pancreatico-biliary disease requires diagnostic or therapeutic ERCP but conventional endoscopic access is not feasible due to surgically altered upper GI anatomy (e.g., Roux-en-Y gastric bypass, hepaticojejunostomy, Whipple reconstruction)failure or infeasibility of standard approaches

    Meta-analyses report pooled enteroscopy success ≈89–90% and diagnostic/therapeutic success with complication rates cited; studies are heterogeneous and largely retrospective.

    inv-07: Dilation of small-bowel strictures in Crohn's disease

    Covered when ALL of the following are met:

    Endoscopic balloon dilation (EBD) via DBE for Crohn's small-bowel strictures: DBE-assisted balloon dilation is indicated for symptomatic, non-complex small-bowel strictures in Crohn's disease to avoid or defer surgery when stricture characteristics are suitableStricture length ≤ 5 cm; absence of fistula, abscess, deep ulceration, or severe adhesion; symptomatic or evidence of proximal dilation on imaging

    Systematic reviews and guidelines report surgery avoided in ~80% and complication rates generally low; Japanese guideline specifies ≤5 cm and absence of associated complications.

    inv-08: Limited evidence / case-series indications

    Covered selectively or considered experimental/limited evidence:

    Limited evidence / case-series indications: DBE-facilitated interventions reported in case series/reports include: endoscopic treatment of post-operative bile leakage after hepatico-jejunostomy; diagnosis of pelvic mass penetrating intestine including gossypiboma; cyanoacrylate injection for small-bowel varices or jejunal varix therapy; and other rare, case-specific therapies. These uses may be considered only when conventional radiologic, endoscopic, or surgical options are infeasible and case-specific justification is provided.absence of feasible alternatives and individual justification

    Evidence limited to small series/case reports; further validation needed.

    The policy lists specific ICD-10 diagnoses that are not covered for the indications in this Clinical Policy Bulletin. These include codes for small intestine malignancies and related neoplasms (e.g., C7A.010–C7A.019, C17.0–C17.9), pelvic mass/pelvic neoplasm (C76.3), secondary malignant neoplasm of the small intestine (C78.4), lymphomas (C81.00–C88.9), benign and malignant carcinoid tumors of the small intestine (D3A.010–D3A.019), intussusception (K56.1), post‑procedural bile leakage (K91.89), pyogenic granuloma (L98.0), intra‑abdominal/pelvic mass codes (R19.00, R19.07, R19.09), and gossypiboma/complications of retained foreign body codes (T81.509A–T81.509S, T81.599A–T81.599S).

    Clinical guidance recommends that capsule endoscopy (CE) is generally used as the initial diagnostic test for small‑bowel evaluation because it is noninvasive and visualizes the entire small bowel; DBE is frequently performed subsequently when CE yields a positive finding that requires biopsy or therapeutic intervention or when CE is contraindicated or nondiagnostic. Documentation of prior CE results or clinical justification for proceeding directly to DBE is expected when CE is feasible.

    For routine primary search of suspected small‑bowel neuroendocrine tumors (NETs), the evidence supports a selective approach: DBE may enrich diagnostic possibilities but reported detection rates are modest and studies recommend performing DBE only in selected cases, typically after a positive or inconclusive prior work‑up rather than as an unconditional first‑line search.

    Studies of DBE‑facilitated ERCP in surgically altered anatomy show variable procedural success and nontrivial complication rates; because most available studies are retrospective and heterogeneous with limited long‑term follow‑up, the policy notes that the definitive effectiveness of therapeutic DBE‑ERCP is unclear and additional larger, longer‑term studies are needed.

    DBE is considered experimental and investigational (not covered) for indications other than those explicitly listed as medically necessary in this policy. Examples include detection of small‑bowel neuroendocrine tumors, diagnosis of pelvic masses penetrating the intestine (including gossypiboma), diagnosis of pyogenic granuloma, treatment of intussusception, and treatment of post‑operative bile leakage after hepatico‑jejunostomy.

    When capsule endoscopy is an appropriate, less invasive option for initial small‑bowel evaluation, the policy cautions against using DBE as the first diagnostic test; CE should be considered first to determine the need for and optimal route of subsequent DBE when indicated.

    The policy states that DBE is not supported as an unconditional first‑line diagnostic test for primary tumor search in all patients with suspected small‑bowel NETs. Available series report modest diagnostic yields and recommend selective use of DBE guided by prior positive or inconclusive investigations.

    In adults with suspected bleeding Meckel's diverticulum, the policy highlights limitations of Meckel's scan: reported diagnostic accuracy of Meckel's scan in adults is low (~21.4% in a multicenter series), and balloon‑assisted enteroscopy (including DBE) demonstrated substantially higher diagnostic accuracy (reported ~85.0%) and is recommended as the preferred preoperative diagnostic modality when noninvasive imaging is negative or inconclusive.

    Coding and billing references

    Polyp size threshold (Peutz-Jeghers) — > 10 mm
    Polyp size threshold (Peutz-Jeghers)> 10 mm
    Stricture length for balloon dilation — <= 5 cm (per Japanese guideline and other reviews)
    Stricture length for balloon dilation<= 5 cm (per Japanese guideline and other reviews)

    Provider actions, prior authorization, and documentation

    Prior Authorization

    Prior authorization — indicate covered indications

    Prior authorization may be required for double balloon enteroscopy (DBE). When prior authorization is requested, clearly indicate that the procedure is being performed for one of the medically necessary indications listed in the policy (e.g., dilation of Crohn’s small-bowel strictures; suspected small-bowel malignancy; incomplete colonoscopy evaluation; suspected Meckel’s diverticulum with indeterminate imaging; investigation of obscure GI bleeding after negative EGD/colonoscopy; initial diagnosis of suspected Crohn’s when conventional tests are negative; removal of retained capsule/foreign body; polypectomy in Peutz‑Jeghers; or DBE to treat a documented small‑intestinal source of bleeding).

    • List the specific indication in the authorization request and attach relevant records (see documentation callouts).
    • If the indication is not one of the listed medically necessary uses, state that DBE is considered experimental/investigational and may be denied.
    Prior Authorization

    Prior testing and justification

    Document prior diagnostic testing and rationale in the request. Capsule endoscopy (CE/VCE) is commonly the recommended initial diagnostic test for obscure GI bleeding and often guides the route and yield of subsequent DBE; when CE is positive, DBE diagnostic yield is substantially higher. If DBE is being requested without prior CE, provide justification (e.g., active/hemodynamically significant bleeding requiring immediate intervention, contraindication to CE, or clinical urgency).

    • Attach results/images from prior CE when available.
    • If CE was negative but clinical suspicion remains high, include explanation and supporting data (ongoing bleeding, transfusion requirement, or imaging suggesting a lesion).
    Prior Authorization

    Prior authorization for DBE in specialized indications

    Prior authorization should be requested for specialized indications where DBE is used for definitive therapy or complex diagnostic situations (for example, surveillance and polypectomy of large small-bowel polyps in Peutz‑Jeghers syndrome, or pre-operative localization of suspected small‑bowel malignancy). Provide disease-specific documentation to support medical necessity.

    • For Peutz‑Jeghers syndrome, include prior imaging (MRE/CT) and polyp size/number and rationale for enteroscopic polypectomy.
    • For suspected malignancy, include imaging, tumor markers, or other findings suggesting neoplasm.
    Prior Authorization

    Prior authorization recommended for complex DBE interventions

    Recommend prior authorization for DBE procedures that are complex or combined with other high‑risk interventions (for example, DBE‑ERCP or enteroscopy‑assisted ERCP in patients with surgically altered anatomy). These procedures have higher technical complexity and complication rates and may warrant review prior to scheduling.

    • When requesting DBE‑ERCP, include prior operative reports describing surgical anatomy (e.g., Roux‑en‑Y, hepaticojejunostomy), prior ERCP attempts, and rationale for enteroscopic approach.
    • State anticipated interventions (sphincterotomy, stone removal, stent placement) and provide relevant imaging/labs.
    Billing Rule

    Coding and indication mismatch

    DBE coding does not have a single, unique CPT code; related CPT/HCPCS codes may be submitted depending on the route and any concurrent procedures (diagnostic enteroscopy, polypectomy, ERCP codes, dilation, foreign‑body removal). Ensure that selected codes match the documented indication and interventions to avoid coding/coverage mismatches.

    • Include narrative describing route (antegrade vs retrograde), procedures performed (biopsy, polypectomy, dilation, foreign‑body extraction), and corresponding CPT/HCPCS codes.
    • If using ERCP CPT/HCPCS codes with enteroscopy, document that papilla/anastomosis was reached and ERCP maneuvers performed.
    Documentation Required

    Technical failure leading to unsuccessful ERCP

    If DBE‑assisted ERCP or enteroscopy fails to reach the papilla or anastomosis, document all attempted routes, technical obstacles (afferent limb entered but anastomosis not reached, angulation, jejunojejunostomy not identified), and reasons for procedural failure. This information is important for claims adjudication and to justify alternative or repeat procedures.

    • Include operative/procedure note detailing routes attempted (oral/anal), length advanced, and specific anatomic/technical barriers.
    • If cannulation failed after reaching the target, document cannulation attempts and methods used.
    Denial Risk

    Risks that may prompt payer review

    DBE‑ERCP and other enteroscopy‑assisted complex interventions carry higher complication rates (including perforation, pancreatitis, cholangitis, bleeding). Requests for high‑risk procedures may be scrutinized; include risk–benefit discussion and prior less‑invasive options attempted.

    • List patient comorbidities that increase procedural risk.
    • Provide rationale why alternative modalities (percutaneous or surgical) are less desirable or not feasible.
    Note

    None specified in this section

    This policy excerpt does not specify additional plan-level step‑therapy requirements or quantity limits for DBE. Providers should still follow standard prior authorization processes and supply complete documentation to support medical necessity.

    • If plan documents elsewhere impose step therapy, that requirement is separate and must be followed.
    Documentation Required

    Indication documentation

    Indication documentation: when submitting a request, include the clinical indication and demonstrate it matches one of the policy's medically necessary indications. Provide presenting symptoms (e.g., overt/obscure GI bleeding, iron‑deficiency anemia, abdominal pain), prior endoscopic findings, and any supporting lab or imaging results.

    • Cite prior EGD/colonoscopy reports showing failure to identify bleeding source for OGIB indications.
    • For Crohn’s dilation, document stricture length, symptoms, and imaging/endoscopic correlation.
    Documentation Required

    Required procedural documentation

    Required procedural documentation: include the indication, pre‑procedure diagnostic findings (e.g., positive CE), detailed procedure note describing route(s) attempted, depth/length advanced, interventions performed (biopsy, polypectomy, dilation, APC, tattooing, foreign‑body extraction), complications, and post‑procedure plan.

    • Attach CE images/reports if available and pathology results for biopsies.
    • If multiple procedures were performed in one session, itemize each and supply corresponding documentation to support coding.
    Documentation Required

    Suggested supporting documentation

    Suggested supporting documentation: include prior diagnostic work‑up (CE, CT/MR enterography, Meckel’s scan, small‑bowel follow‑through), laboratory data (hemoglobin, iron studies), transfusion history, and prior procedure reports that establish persistence of symptoms or ongoing bleeding.

    • For suspected Meckel’s diverticulum, include Meckel’s scan results and rationale for proceeding to DBE if scan was negative but suspicion remains.
    • For OGIB, provide serial hemoglobin trends and transfusion needs.
    Documentation Required

    Use diagnostic algorithm

    Use a diagnostic algorithm: in obscure GI bleeding, perform standard upper and lower endoscopies first; CE is generally the preferred initial small‑bowel diagnostic test because it is noninvasive and can direct DBE route selection; DBE is often used for therapy or biopsy after CE localization.

    • If CE is positive, include CE findings to justify targeted DBE.
    • If CE is not performed, document contraindication or clinical urgency requiring direct DBE.
    Documentation Required

    Use of capsule endoscopy before DBE

    Use of capsule endoscopy before DBE: CE is generally recommended as the initial diagnostic test for obscure GI bleeding due to its ability to visualize the entire small bowel and to guide subsequent DBE; when DBE is requested following a positive CE, diagnostic yield is higher.

    • Attach CE report/images if available to prior authorization request.
    • When CE showed only blood in lumen, note that DBE may clarify the source in a substantial proportion of cases.
    Documentation Required

    Consider referral/step-up to specialized center

    Consider referral/step‑up to a specialized or high‑volume center when ERCP is required in patients with surgically altered anatomy or when prior enteroscopy attempts have failed. High‑volume centers may achieve higher enteroscopic and ERCP success rates and lower need for alternative invasive procedures.

    • If local facility lacks DBE‑ERCP capability, document referral attempts or rationale for out‑of‑network care.
    • Include prior unsuccessful attempts and reasons when requesting authorization for referral.
    Documentation Required

    Noninvasive studies prior to DBE

    Noninvasive studies prior to DBE: consider CT or MR enterography, Meckel’s scan (for suspected Meckel’s), angiography when active bleeding is suspected, and CE as part of the diagnostic work‑up; include these results in the authorization request to support necessity of DBE.

    • For Meckel’s suspicion, include Meckel’s scan and CT/MR findings; note that BAE/DBE may be preferred when other modalities are indeterminate.
    • If imaging suggests a lesion amenable to endoscopic therapy, document findings and prior noninvasive test dates.
    Note

    No step therapy requirements are specified

    No step therapy requirements for DBE are specified within this policy excerpt. Providers should follow the payer's general authorization processes and any other plan‑specific utilization management rules that may apply.

    • If a plan's medical management system indicates step requirements elsewhere, comply with those external requirements.

    Background and context

    Double‑balloon enteroscopy is an endoscopic technique that uses an enteroscope and overtube with two balloons to pleat and advance the scope through the small intestine via oral (anterograde) or anal (retrograde) routes. It permits deep small‑bowel visualization and enables diagnostic sampling and therapeutic interventions (for example, polypectomy, argon plasma coagulation, dilation, stent placement, or foreign‑body removal) over longer lengths of small bowel than push enteroscopy, though it typically requires longer procedure time, additional sedation, and sometimes fluoroscopic assistance.

    Definitions and key terms

    Double balloon enteroscopy (DBE) — device and scope description
    Device descriptionDBE employs a 200-cm enteroscope and a 140-cm overtube, each with balloons used to pleat and advance the scope through the small intestine via oral (anterograde) or anal (retrograde) approaches.
    Balloon designTwo balloons: one at the tip of the enteroscope and one at the distal end of the overtube; overtube balloon grips intestinal wall to prevent loop formation.
    Scope typesThin observation endoscope (for stepwise examination) and therapeutic double-balloon endoscope (larger accessory channel for interventions).
    Obscure gastrointestinal bleeding (OGIB) — definition
    OGIB definitionRecurrent small intestinal bleeding (e.g., iron-deficiency anemia, positive fecal occult blood, or visible bleeding) after negative upper and lower endoscopies.
    Clinical contextOGIB is a major indication for DBE when EGD and colonoscopy fail to identify a bleeding source.
    Typical work-upEvaluation usually follows negative upper and lower endoscopy and may include capsule endoscopy prior to DBE.
    Obscure gastrointestinal bleeding (OGIB) — alternate definition
    Alternate OGIB descriptionBleeding of unknown origin persisting or recurring after initial negative upper and lower endoscopy; often evaluated with capsule endoscopy and DBE.
    Role of CECapsule endoscopy is recommended as the initial diagnostic test for OGIB because it is noninvasive and can determine the initial route for DBE.
    Indication importanceOGIB is among the principal clinical scenarios in which DBE is indicated based on evidence and meta-analyses.
    DB-ERCP — definition
    DB-ERCP definitionEndoscopic retrograde cholangio-pancreatography performed using a double-balloon enteroscope to access the papilla or biliary-enteric anastomosis in patients with surgically altered GI anatomy.
    IndicationsUsed when conventional ERCP is not feasible due to altered anatomy (e.g., Roux-en-Y, Billroth II, pancreatoduodenectomy).
    Technical noteMay employ short-type DBE and technical innovations (attachments, tattooing, CO2 insufflation) to reach blind end and facilitate cannulation and therapy.
    BAE / DBE — balloon-assisted endoscopy definition
    BAE / DBE definitionBalloon-assisted endoscopy (BAE), specifically double-balloon enteroscopy (DBE), is an endoscopic method using balloons to advance the enteroscope for deep small-bowel visualization and intervention.
    FunctionBalloons are alternately inflated/deflated on the scope and overtube to pleat the intestine and permit further advancement without excessive looping.
    ApproachesCan be performed via oral (anterograde) or anal (retrograde) routes to visualize extensive portions of the small bowel.
    DBE-ERCP — use to reach and perform ERCP in altered anatomy
    Clinical useDBE-ERCP is used to reach and perform ERCP in patients with surgically altered upper GI anatomy when conventional endoscopes cannot access the papilla or biliary anastomosis.
    OutcomesStudies report high enteroscopic success and reasonable diagnostic/therapeutic success but note technical challenges and potential complications.
    ConsiderationReferral to high-volume centers may be appropriate for complex altered-anatomy ERCP cases prior to surgical or percutaneous alternatives.
    Meckel's scan — technetium-99m pertechnetate scintigraphy definition
    Meckel's scan definitionTechnetium-99m pertechnetate scintigraphy (Meckel's scan) is a radioisotope imaging test traditionally considered the pediatric gold standard for bleeding Meckel's diverticulum.
    Adult accuracyIn adults, Meckel's scan has low diagnostic accuracy compared with BAE/DBE in the cited multi-center study (Meckel's scan accuracy 21.4%).
    Role in work-upMeckel's scan is part of the diagnostic imaging work-up but DBE/BAE may be preferred pre-operatively when Meckel's scan is negative or nondiagnostic.
    DBE-ERCP — alternate definition entry
    DBE-ERCP alternate definitionERCP performed using double-balloon enteroscopy techniques to access the pancreatico-biliary tree in patients with surgically altered anatomy to achieve diagnostic and therapeutic goals.
    Evidence summaryMeta-analyses report pooled enteroscopic success ~90% and procedural/diagnostic success with complication rates that warrant experienced operators and consideration of referral.
    Clinical implicationDBE-ERCP is a feasible option when standard ERCP is not possible, but studies are heterogeneous and long-term comparative data are limited.